secwatch / observer
8-K filed June 18, 2026, 5:04 PM ET ticker RXRX CIK 0001601830
other confidence high sentiment neutral materiality 0.15

Recursion Pharma 2026 annual meeting elects directors, approves exec compensation, ratifies auditor

RECURSION PHARMACEUTICALS, INC.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

RECURSION PHARMACEUTICALS, INC. shareholders approved Election of Class II directors at the 2026-06-17 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-06-17
Exact text from the filing
Proposal 1: The stockholders elected as Class II directors the two individuals listed below to serve until the Company’s 2029 annual meeting of stockholders, or until their respective successors are duly elected and qualified. The voting results were as follows: Nominee For Withheld Broker Non-Votes Najat Khan, Ph.D. 210,437,751 27,907,256 126,675,762 Franziska Michor, Ph.D. 208,124,737 30,220,270 126,675,762
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

RECURSION PHARMACEUTICALS, INC. shareholders approved Advisory vote to approve executive compensation at the 2026-06-17 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-06-17
Exact text from the filing
Proposal 2: The advisory resolution to approve executive compensation, as disclosed in the Proxy Statement, was approved, with the following votes cast: For Against Abstain Broker Non-Votes 206,171,008 30,893,147 1,280,852 126,675,762
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

RECURSION PHARMACEUTICALS, INC. shareholders approved Ratification of appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm at the 2026-06-17 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-06-17
Exact text from the filing
Proposal 3: The appointment of PricewaterhouseCoopers LLP as independent registered public accounting firm for the year ending December 31, 2026 was ratified, with the following votes cast: For Against Abstain 361,743,500 2,148,771 1,128,498
View on SEC.gov

1183 shareholder votes filed in the last 30 days. Browse all shareholder votes →

RECURSION PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR
accession 0001601830-26-000080
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.